mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-06 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-05 |
mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0001 |